help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPENCER, S.
Right arrow Articles by JONES, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPENCER, S.
Right arrow Articles by JONES, P. W.

Am. J. Respir. Crit. Care Med., Volume 163, Number 1, January 2001, 122-128

Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease

SALLY SPENCER, PETER M. A. CALVERLEY, P. SHERWOOD BURGE, and PAUL W. JONES, on behalf of the ISOLDE Study Group

Department of Physiological Medicine, St George's Hospital Medical School, London, United Kingdom

This study examined health status decline in patients with chronic obstructive pulmonary disease (COPD). Data are from the Inhaled Steroids in Obstructive Lung Disease (ISOLDE) trial. After an 8-wk run-in, 751 patients (566 male), mean age 64 yr, were randomized to receive fluticasone propionate (FP) 500 µg twice daily (376 patients) or placebo (375 patients). Mean baseline postbronchodilator FEV1 was 50 ± 15% predicted. Patients completed the St George's Respiratory Questionnaire (SGRQ) and the Short-Form 36 (SF-36) at baseline and every 6 mo for 3 yr. FEV1 and smoking status were assessed at baseline and at 3-mo intervals. A total of 387 (212 FP) patients completed the trial. All SGRQ components (p = 0.03 to 0.004) and Physical Function, Mental Health, Energy/ Vitality, and Physical Role Limitation scales of the SF-36 (p = 0.05 to 0.005) deteriorated faster in the placebo group. FEV1 and SGRQ scores correlated at baseline values (r = -0.25, p < 0.0001), as did change in FEV1 and change in SGRQ (Delta  r = -0.24, p < 0.0001). At baseline values smokers had worse SGRQ Total, Symptoms, and Impacts scores than ex-smokers. This difference was maintained throughout the study. Smoking status did not influence the rate of decline in health status. The SGRQ Total scores of FP-treated patients took 59% longer than placebo to deteriorate by a clinically significant amount. We conclude that health status decline in moderate to severe COPD can be reduced by high-dose fluticasone.




This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
O. A. Minai, J. Benditt, and F. J. Martinez
Natural History of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 468 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Anzueto, S. Sethi, and F. J. Martinez
Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, October 1, 2007; 4(7): 554 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Osman, J. G. Douglas, C. Garden, K. Reglitz, J. Lyon, S. Gordon, and J. G. Ayres
Indoor Air Quality in Homes of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 465 - 472.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
M. Decramer
Tiotropium as essential maintenance therapy in COPD
Eur. Respir. Rev., December 1, 2006; 15(99): 51 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Decramer and R. Gosselink
Physical activity in patients with cystic fibrosis: a new variable in the health-status equation unravelled?
Eur. Respir. J., October 1, 2006; 28(4): 678 - 679.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. W. Jones
Health Status: What Does It Mean for Payers and Patients?
Proceedings of the ATS, May 1, 2006; 3(3): 222 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Leigh, M. M. M. Pizzichini, M. M. Morris, F. Maltais, F. E. Hargreave, and E. Pizzichini
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Eur. Respir. J., May 1, 2006; 27(5): 964 - 971.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
G. Gartlehner, R. A. Hansen, S. S. Carson, and K. N. Lohr
Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes
Ann. Fam. Med, May 1, 2006; 4(3): 253 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Eaton, W. Fergusson, J. Kolbe, C. A. Lewis, and T. West
Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study.
Eur. Respir. J., April 1, 2006; 27(4): 697 - 704.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. W. Jones and A. G. N. Agusti
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
Eur. Respir. J., April 1, 2006; 27(4): 822 - 832.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E Sapey and R A Stockley
COPD exacerbations {middle dot} 2: Aetiology.
Thorax, March 1, 2006; 61(3): 250 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
T Eaton, P Young, K Nicol, and J Kolbe
The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients
Chronic Respiratory Disease, January 1, 2006; 3(1): 3 - 9.
[Abstract] [PDF]

Home page
 ChestHome page
M. Albers, T. Schermer, and C. van Weel
Airflow Limitation as a Screening Tool
Chest, October 1, 2005; 128(4): 1898 - 1900.
[Full Text] [PDF]

Home page
 ChestHome page
G. Xie, Y. Li, P. Shi, B. Zhou, P. Zhang, and Y. Wu
Baseline Pulmonary Function and Quality of Life 9 Years Later in a Middle-Aged Chinese Population
Chest, October 1, 2005; 128(4): 2448 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. K. Myint, R. N. Luben, P. G. Surtees, N. W. J. Wainwright, A. A. Welch, S. A. Bingham, N. J. Wareham, N. E. Day, and K-T. Khaw
Respiratory function and self-reported functional health: EPIC-Norfolk population study
Eur. Respir. J., September 1, 2005; 26(3): 494 - 502.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
R. Wilson
Treatment of COPD exacerbations: antibiotics
Eur. Respir. Rev., September 1, 2005; 14(94): 32 - 38.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J J Swigris, W G Kuschner, S S Jacobs, S R Wilson, and M K Gould
Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review
Thorax, July 1, 2005; 60(7): 588 - 594.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Needham and R. A. Stockley
Exacerbations in {alpha}1-antitrypsin deficiency
Eur. Respir. J., June 1, 2005; 25(6): 992 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Alvarez-Mon, M. Miravitlles, J. Morera, L. Callol, and J. L. Alvarez-Sala
Treatment With the Immunomodulator AM3 Improves the Health-Related Quality of Life of Patients With COPD
Chest, April 1, 2005; 127(4): 1212 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Vestbo, R Pauwels, J A Anderson, P Jones, P Calverley, and on behalf of the TRISTAN study group
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease
Thorax, April 1, 2005; 60(4): 301 - 304.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Decramer, R Gosselink, P Bartsch, C-G Lofdahl, W Vincken, R Dekhuijzen, J Vestbo, R Pauwels, R Naeije, and T Troosters
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004
Thorax, April 1, 2005; 60(4): 343 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Laghi, A. Antonescu-Turcu, E. Collins, J. Segal, D. E. Tobin, A. Jubran, and M. J. Tobin
Hypogonadism in Men with Chronic Obstructive Pulmonary Disease: Prevalence and Quality of Life
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 728 - 733.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. J. Swigris, M. K. Gould, and S. R. Wilson
Health-Related Quality of Life Among Patients With Idiopathic Pulmonary Fibrosis
Chest, January 1, 2005; 127(1): 284 - 294.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Albers, T. Schermer, G. van den Boom, R. Akkermans, C. van Schayck, C. van Herwaarden, and C. van Weel
Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD: Results of the Detection, Intervention, and Monitoring of COPD and Asthma Program
Chest, December 1, 2004; 126(6): 1815 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. W. Jones
Clinical Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 167 - 170.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. Marchand
Withdrawal From and Study Design of the ISOLDE Trial
Chest, August 1, 2004; 126(2): 659 - 659.
[Full Text] [PDF]

Home page
 NEJMHome page
E. R. Sutherland and R. M. Cherniack
Management of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 24, 2004; 350(26): 2689 - 2697.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Spencer, P.M.A. Calverley, P.S. Burge, and P.W. Jones
Impact of preventing exacerbations on deterioration of health status in COPD
Eur. Respir. J., May 1, 2004; 23(5): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Miravitlles, M Ferrer, A Pont, R Zalacain, J L Alvarez-Sala, F Masa, H Verea, C Murio, F Ros, and R Vidal
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study
Thorax, May 1, 2004; 59(5): 387 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. I. Rennard and S. G. Farmer
Exacerbations and Progression of Disease in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 88 - 92.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. E. Cox, J. F. Donohue, C. D. Brown, Y. P. Kataria, and M. A. Judson
Health-Related Quality of Life of Persons With Sarcoidosis
Chest, March 1, 2004; 125(3): 997 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Stolk, W H Ng, M E Bakker, J H C Reiber, K F Rabe, H Putter, and B C Stoel
Correlation between annual change in health status and computer tomography derived lung density in subjects with {alpha}1-antitrypsin deficiency
Thorax, December 1, 2003; 58(12): 1027 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. D. Sin, F. A. McAlister, S. F. P. Man, and N. R. Anthonisen
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
JAMA, November 5, 2003; 290(17): 2301 - 2312.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E R Sutherland, H Allmers, N T Ayas, A J Venn, and R J Martin
Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis
Thorax, November 1, 2003; 58(11): 937 - 941.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
I. F. Oey, M. D.L. Morgan, S. J. Singh, T. J. Spyt, and D. A. Waller
The long-term health status improvements seen after lung volume reduction surgery
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 614 - 619.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S Spencer and P W Jones
Time course of recovery of health status following an infective exacerbation of chronic bronchitis
Thorax, July 1, 2003; 58(7): 589 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.S. Buist
Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Eur. Respir. J., January 1, 2003; 21(39_suppl): 30S - 35s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. van der Valk, E. Monninkhof, J. van der Palen, G. Zielhuis, and C. van Herwaarden
Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: The COPE Study
Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1358 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. J. Schunemann, G. H. Guyatt, L. Griffith, D. Stubbing, and R. Goldstein
A Randomized Controlled Trial To Evaluate the Effect of Informing Patients About Their Pretreatment Responses to Two Respiratory Questionnaires
Chest, November 1, 2002; 122(5): 1701 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. J. Dowson, P. J. Guest, and R. A. Stockley
The Relationship of Chronic Sputum Expectoration to Physiologic, Radiologic, and Health Status Characteristics in {alpha}1-Antitrypsin Deficiency (PiZ)
Chest, October 1, 2002; 122(4): 1247 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Ferrer, C. Villasante, J. Alonso, V. Sobradillo, R. Gabriel, G. Vilagut, J.F. Masa, J.L. Viejo, C.A. Jimenez-Ruiz, and M. Miravitlles
Interpretation of quality of life scores from the St George's Respiratory Questionnaire
Eur. Respir. J., March 1, 2002; 19(3): 405 - 413.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. D. Aaron, K. L. Vandemheen, J. J. Clinch, J. Ahuja, R. J. Brison, G. Dickinson, and P. C. Hebert
Measurement of Short-term Changes in Dyspnea and Disease-Specific Quality of Life Following an Acute COPD Exacerbation
Chest, March 1, 2002; 121(3): 688 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Casaburi, D.A. Mahler, P.W. Jones, A. Wanner, G. San Pedro, R.L. ZuWallack, S.S. Menjoge, C.W. Serby, and T. Witek Jr
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2002; 19(2): 217 - 224.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P W Jones
Health status measurement in chronic obstructive pulmonary disease
Thorax, November 1, 2001; 56(11): 880 - 887.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A E Tattersfield and T W Harrison
Inhaled steroids for COPD?
Thorax, September 1, 2001; 56(90002): ii2 - 6.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer
Epidemiology of chronic obstructive pulmonary disease
Eur. Respir. J., May 1, 2001; 17(5): 982 - 994.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society